Comparison of administration of oral versus Infusions intravenous iron therapy in diabetic patients with chronic kidney disease receiving Erythropoietin
View Full Paper
Ask AI
Bookmark
Share
Key Points
Intravenous iron therapy significantly improved anemia in 61.1% of patients after four weeks, while oral therapy succeeded in only 33.3%.
With a p-value of 0.001, intravenous iron demonstrated superior efficacy among older patients aged 56-70 compared to oral consumption.
Retrospective comparative analysis utilized patient records from 144 diabetic CKD patients to assess treatment outcomes.
These findings suggest intravenous iron may be the preferred treatment option for diabetic CKD patients receiving Erythropoietin.
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Retrospective study compares iron therapy types in diabetic patients with CKD, revealing IV iron enhances anemia recovery.